In summary, we have obtained an IL13Rα2-specific antibody 5.5.4 that can inhibit IL-13-mediated FAK, Src and AKT signaling to suppress metastatic liver colonization in colorectal cancer. This evidence concerns the gene PTK2 and colorectal cancer.